Trump Didn't 'Cancel Cancer Research' — But His Directives Paused NIH Meetings To Dole Out Funds
Meetings designed to distribute grant money to fund research were canceled as part of a communications freeze at health ...
NIH funding is critical for Philadelphia-area research institutes. It’s threatened under a Trump administration freeze.
Major academic research institutions and medical schools in the Philadelphia region are allotted $1.7 billion in NIH funding.
Medscape6d
NIH Meeting Cancellations Could Impact Cancer Research
Cancellations of NIH grant review panels, in particular, could affect cancer research grants and funding. In these NIH grant ...
I’m a health researcher. NIH’s pause on research grants could have a devastating cost.
I’m a health researcher. NIH’s pause on research grants could have a devastating cost. This is a potentially devastating ...
Mother Jones6d
What the Hell Is Going on at NIH?
Chrystal Starbird, a cancer researcher at the University of North Carolina School of Medicine, had been preparing to serve on ...
Futurism on MSN2d
Trump Administration Throws Cancer Research Into Turmoil
During Donald Trump's draconian first-week rollbacks, cancer research and other crucial medical projects have been paused ...
Cancer research has kept his daughter alive. He says now-reversed Trump funding freeze was ‘inhumane.’
South Florida beneficiaries of federal grant and loan programs were jolted when President Donald Trump ordered a freeze, now ...
Trump’s pause of science is harming real people
Trump's freeze on federal grants and loans could total trillions of dollars and cause disruptions in health care research, ...
Unintended consequences of halting vaccine research: more cancer deaths?
Like infectious diseases, cancer will not observe a moratorium, and a halt in government vaccine research funding will ...
Feds cancel research meetings, raising fears in Oregon about jobs, hundreds of millions in funding
Experts in every field of medical research gather at meetings to decide which topics and projects are most deserving of funds ...
EurekAlert!2d
In HER2+ colorectal cancer, anti-HER2 therapy may be less toxic alternative
A phase 2 trial finds that for patients with HER2+ metastatic colorectal cancer, dual HER2-inhibitor therapy can be a similarly efficacious but less toxic alternative to EGFR inhibitor therapy.